Bluejay Diagnostics (BJDX) Operating Leases (2022 - 2026)

Bluejay Diagnostics has disclosed Operating Leases across 5 years of filings, most recently posting $105328.0 for Q1 2026.

• Operating Leases for Q1 2026 came in at $105328.0, up 20.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $105328.0 (up 20.55% YoY), and the FY2025 annual result was $129558.0, up 18.87% from the prior year.
• Operating Leases came in at $105328.0 for Q1 2026 at Bluejay Diagnostics, down from $129558.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $601647.0 in Q2 2022 to a low of $18027.0 in Q3 2023.
• The 5-year median for Operating Leases is $170703.0 (2024), against an average of $231554.2.
• Across the five-year window, Operating Leases plunged 94.94% in 2023 and surged 622.24% in 2024, its largest moves.
• Bluejay Diagnostics' Operating Leases stood at $323915.0 in 2022, then increased by 14.26% to $370105.0 in 2023, then tumbled by 70.55% to $108989.0 in 2024, then rose by 18.87% to $129558.0 in 2025, then fell by 18.7% to $105328.0 in 2026.
• The last three Operating Leases figures came in at $105328.0 (Q1 2026), $129558.0 (Q4 2025), and $142992.0 (Q3 2025), per Business Quant data.